Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.
The therapeutic use of cannabinoids: Forensic aspects.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Pediatric multiple sclerosis.
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study.
Multiple sclerosis.
Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
Early detection of thrombin activity in neuroinflammatory disease.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Immunity and inflammation in neurodegenerative diseases.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Neuroinflammation: no rose by any other name.
Pages
« first
‹ previous
…
586
587
588
589
590
591
592
593
594
…
next ›
last »